Pegasys Catching Up To PEG-Intron; Schering Admits “Complacency”

Schering-Plough plans to focus more directly on maintaining market share in the pegylated interferon market after losing about one-third of its share to Roche, Global Pharmaceuticals President Carrie Cox told a July 23 conference call